Supplementary Material
glioblastoma, tumor, tumors, Tumor
GLIOBLASTOMA, TUMOR, TUMORS, TUMOR
Table S1. Representativeness of Study ParticipantsClick here for additional data file.Table S2. Key Antibodies ResourceClick here for additional data file.Tumor molecular characteristicsClick here for additional data file.One-way ANOVA analysis comparing expression of cytokines between Avelumab treated and Avelumab combined with BevacizumabClick here for additional data file.Sex as a variable of survivalClick here for additional data file.Chromogenic multiplex expression analysis of different biomarkers in formalin-fixed paraffin-embedded tissue of a patient's tumor when diagnosed with glioblastoma (34369), before treated with LITT (34370) and after treatment with LITT and avelumab (34371) and quantitative analysis using Halo® Image Analysis Platform.Click here for additional data file.Chromogenic multiplex expression analysis of different biomarkers in formalin-fixed paraffin-embedded tissue of 34364, 34368, 34369, 34370, and 34371 tumors and quantitative analysis using Halo® Image Analysis PlatformClick here for additional data file.